Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Regulatory News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sensyne Health

15 Jun 2022 18:00

RNS Number : 9681O
FTSE Russell
15 June 2022
 

 

 

Sensyne Health (UK): Constituent DeletionChanges in FTSE UK Index Series

15 June 2022

Subject to the expected cancellation of trading on AIM for Sensyne Health (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE AIM All-Share Index

20 June 2022

 

 

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 6441 1440

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

Alternatively please visit our website at www.ftserussell.com

 

Terms of Use | Copyright © 2022 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSGCGDLDUBDGDU
Date   Source Headline
31st Jul 20197:00 amRNSCollaboration Agreement with Bayer
9th Jul 20197:00 amRNSHoldings in Company
1st Jul 20192:05 pmRNSSecond Price Monitoring Extn
1st Jul 20192:00 pmRNSPrice Monitoring Extension
27th Jun 20194:48 pmRNSHolding(s) in Company
27th Jun 20194:42 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSEY announcement on AI and blockchain
24th Jun 20197:00 amRNSLAB10x partnership for data-driven drug discovery
30th Apr 20197:00 amRNSBayer joins Sensyne Health consortium
28th Jan 20197:02 amRNSResearch alliance with Big Data Institute
28th Jan 20197:02 amRNSAgreement with Jefferson Health in US
28th Jan 20197:02 amRNSSigns SRA with Wye Valley NHS Trust
28th Jan 20197:02 amRNSSigns SRA with George Eliot Hospital NHS Trust
28th Jan 20197:02 amRNSSensyne Health Maiden Interim Results 2018
15th Jan 20197:00 amRNSNotice of Interim Results
5th Dec 201810:41 amRNSAnnouncement on National Health Data
21st Nov 20187:00 amRNSStrategic advisory services agreement with EY
24th Oct 20187:00 amRNSBoard Change
16th Oct 20187:00 amRNSOfficial product launch of GDm-HealthT
3rd Oct 20187:00 amRNSBoard Appointment
2nd Oct 20187:00 amRNSChange of Registered Office
28th Sep 201811:56 amRNSHolding(s) in Company
6th Sep 20181:19 pmRNSSensyne Health welcomes government code of conduct
21st Aug 20183:28 pmRNSHoldings in Company
20th Aug 20185:32 pmRNSHoldings in Company
20th Aug 20184:52 pmRNSHoldings in Company
17th Aug 20188:04 amRNSAdmission to AIM & First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.